GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Balchem Corp (NAS:BCPC) » Definitions » Cash Flow from Financing

BCPC (Balchem) Cash Flow from Financing : $-135.8 Mil (TTM As of Mar. 2025)


View and export this data going back to 1986. Start your Free Trial

What is Balchem Cash Flow from Financing?

Cash from financing is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders.

For the three months ended in Mar. 2025, Balchem paid $5.3 Mil more to buy back shares than it received from issuing new shares. It spent $0.0 Mil paying down its debt. It paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares. It spent $28.3 Mil paying cash dividends to shareholders. It received $1.7 Mil on other financial activities. In all, Balchem spent $32.0 Mil on financial activities for the three months ended in Mar. 2025.


Balchem Cash Flow from Financing Historical Data

The historical data trend for Balchem's Cash Flow from Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Balchem Cash Flow from Financing Chart

Balchem Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow from Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -101.16 -102.18 246.68 -153.32 -133.82

Balchem Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cash Flow from Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -30.02 -34.19 -34.39 -35.21 -31.97

Balchem Cash Flow from Financing Calculation

This is the cash generated/spent from financial activities such as share issuance (buy back), debt issuance (repayment), and dividends paid to preferred and common stockholders. In the calculation of free cash flow, cash from financing is not calculated because it is not related to operating activities.

Balchem's Cash from Financing for the fiscal year that ended in Dec. 2024 is calculated as:

Balchem's Cash from Financing for the quarter that ended in Mar. 2025 is:


Cash Flow from Financing for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-135.8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Balchem  (NAS:BCPC) Cash Flow from Financing Explanation

Cash from financing contains six items:

1. Issuance of Stock:
A company may raise cash from issuing new shares. Issuance of stock represents the cash inflow from offering common stock, which is the additional capital contribution to the entity during the period.

Balchem's issuance of stock for the three months ended in Mar. 2025 was $0.0 Mil.

2. Repurchase of Stock:
A company may raise cash from issuing new shares. It can also use cash to buy back shares. Repurchase of stock represents the cash outflow to reacquire common stock during the period.

Balchem's repurchase of stock for the three months ended in Mar. 2025 was $-5.3 Mil.

3. Net Issuance of Debt:
Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Balchem's net issuance of debt for the three months ended in Mar. 2025 was $-0.0 Mil. Balchem spent $0.0 Mil paying down its debt.

4. Net Issuance of Preferred Stock:
A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Balchem's net issuance of preferred for the three months ended in Mar. 2025 was $0.0 Mil. Balchem paid $0.0 Mil more to buy back preferred shares than it received from issuing preferred shares.

5. Cash Flow for Dividends:
Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Balchem's cash flow for dividends for the three months ended in Mar. 2025 was $-28.3 Mil. Balchem spent $28.3 Mil paying cash dividends to shareholders.

6. Other Financing:
Money spent or earned by company from other financial activities.

Balchem's other financing for the three months ended in Mar. 2025 was $1.7 Mil. Balchem received $1.7 Mil on other financial activities.


Balchem Cash Flow from Financing Related Terms

Thank you for viewing the detailed overview of Balchem's Cash Flow from Financing provided by GuruFocus.com. Please click on the following links to see related term pages.


Balchem Business Description

Traded in Other Exchanges
Address
5 Paragon Drive, Montvale, NJ, USA, 07645
Balchem Corp is engaged in the development, manufacture, and marketing of specialty performance ingredients and products for various industries. The company's reportable segments are; Human Nutrition and Health, which generates maximum revenue, and provides human-grade choline nutrients and mineral amino acid chelated products through this segment for nutrition and health applications; Animal Nutrition and Health, which provides nutritional products derived from its microencapsulation and chelation technologies in addition to the essential nutrient choline chloride; and the Specialty Products segment includes re-packaging and distributing several performance gases and chemicals. Geographically, the company derives its key revenue from the United States and the rest from foreign countries.
Executives
Van Gunsteren Job Leonard officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
William A. Backus officer: Chief Accounting Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Michael Robert Sestrick officer: Chief Technology Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
David B Fischer director 425 WINTER ROAD, DELAWARE OH 43015
Michael Bent Tignor officer: Chief Human Resources Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Matthew David Wineinger director 3605 GRAND VIEW COURT, ST CHARLES IL 60175
Theodore L Harris director, officer: President and CEO 5200 BLAZER PARKWAY, DUBLIN OH 43017
Olivier Rigaud director CORBION NV, PIET HEINKADE 127, AMSTERDAM P7 1019 GM
Monica Vicente director C/O FRESH DEL MONTE PRODUCE INC., P.O. BOX 149222, CORAL GABLES FL 33114
Frederic Boned officer: SVP/GM, Human Nutri. & Health 5 PARAGON DRIVE, MONTVALE NJ 07645
Hatsuki Miyata officer: General Counsel and Secretary 5 PARAGON DRIVE, MONTVALE NJ 07645
Jonathan Harrison Griffin officer: Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Martin Luther Reid officer: Chief Supply Chain Officer 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958
Kathleen B Fish director ONE PROCTER & GAMBLE PLAZA, CINCINNATI OH 45202
James C Hyde officer: Sr. Vice President 52 SUNRISE PARK ROAD, NEW HAMPTON NY 10958